Crossmark

Design and development of nanoprobes radiolabelled with 99mTc for the diagnosis and monitoring of therapeutic interventions in oncology preclinical research

Crossref DOI link: https://doi.org/10.1186/s41181-024-00300-z

Published Online: 2024-10-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Salgueiro, María Jimena

Portillo, Mariano

Tesán, Fiorella

Nicoud, Melisa

Medina, Vanina

Moretton, Marcela

Chiappetta, Diego

Zubillaga, Marcela https://orcid.org/0000-0002-7331-6722
Funding

Funding for this research was provided by:

Secretaria de Ciencia y Tecnica, Universidad de Buenos Aires (20020220300178BA)
License Information

Text and Data Mining valid from 2024-10-29

Version of Record valid from 2024-10-29
More Information

Article History

Received: 23 July 2024

Accepted: 19 September 2024

First Online: 29 October 2024

Declarations

:

: All procedures performed with animals are approved by the Institutional Commission for the Care and Use of Laboratory Animals (CICUAL) of the School of Pharmacy and Biochemistry, University of Buenos Aires (Res (D) N°671/18). All methods were carried out in accordance with CICUAL and ARRIVE guidelines and regulations.

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below